US FDA May Lose Some Autonomy Under HHS General Counsel Reorganization

 
• By Sarah Karlin-Smith
  
person in business suit holding giant magnifying glass looking down at smaller people in business suits.
The new HHS Office of General Counsel reorganization may indicate more micromanagement of the FDA is coming. (Shutterstock)
HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

SpotifyApple PodcastsWebsite

More from Legal

More from HBW Insight